Your browser doesn't support javascript.
loading
Autohydrolysis of Diglycine-Activated Succinic Esters Boosts Cellular Uptake.
Guo, Jiaqi; Tan, Weiyi; He, Hongjian; Xu, Bing.
Afiliação
  • Guo J; Department of Chemistry, Brandeis University 415, Waltham, MA 02454, USA.
  • Tan W; Department of Chemistry, Brandeis University 415, Waltham, MA 02454, USA.
  • He H; Department of Chemistry, Brandeis University 415, Waltham, MA 02454, USA.
  • Xu B; Department of Chemistry, Brandeis University 415, Waltham, MA 02454, USA.
Angew Chem Int Ed Engl ; 62(36): e202308022, 2023 09 04.
Article em En | MEDLINE | ID: mdl-37468437
ABSTRACT
Rapid cellular uptake of synthetic molecules remains a challenge, and the motif frequently employed to generate prodrugs, succinic ester, unfortunately lowers the efficacy of the desired drugs due to their slow ester hydrolysis and low cell entry. Here we show that succinic ester-containing diglycine drastically boosts the cellular uptake of supramolecular assemblies or prodrugs. Specifically, autohydrolysis of the diglycine-activated succinic esters turns the nanofibers of the conjugates of succinic ester and self-assembling motif into nanoparticles for fast cellular uptake. The autohydrolysis of diglycine-activated succinic esters and drug conjugates also restores the efficacy of the drugs. 2D nuclear magnetic resonance (NMR) suggests that a "U-turn" of diglycine favors intramolecular hydrolysis of diglycine-activated succinic esters to promote autohydrolysis. As an example of rapid autohydrolysis of diglycine-activated succinic esters for instant cellular uptake, this work illustrates a nonenzymatic bond cleavage approach to develop effective therapeutics for intracellular targeting.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos Idioma: En Ano de publicação: 2023 Tipo de documento: Article